Dysphoric
Bluelighter
- Joined
- Feb 3, 2010
- Messages
- 392
Since we're talking about Re-uptake inhibitors. I would like to shine some light on Diclofensine. It sounds somewhat promising.
Anyways, I'm still trying to figure this out. Why was it dropped from clinical development, possibly due to concerns about its abuse potential? Why does it matter if it has abuse potential? Especially if it can benefit people. It even states that it had benign side-effects, so why would it matter if a few people abused it? I'm so mad!
However, this one is still on human trials ATM and also looks interesting, it's another Triple monoamine reuptake inhibitor (SNDRI) Amitifadine.
Anyways, I'm still trying to figure this out. Why was it dropped from clinical development, possibly due to concerns about its abuse potential? Why does it matter if it has abuse potential? Especially if it can benefit people. It even states that it had benign side-effects, so why would it matter if a few people abused it? I'm so mad!
However, this one is still on human trials ATM and also looks interesting, it's another Triple monoamine reuptake inhibitor (SNDRI) Amitifadine.
Last edited: